Han Wenqiang, Wang Wenxin, Wang Qinhong, Maduray Kellina, Hao Li, Zhong Jingquan
National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
Department of Gerontology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Front Pharmacol. 2024 Feb 13;15:1267585. doi: 10.3389/fphar.2024.1267585. eCollection 2024.
Myocardial infarction (MI) imposes a huge medical and economic burden on society, and cardiac repair after MI involves a complex series of processes. Understanding the key mechanisms (such as apoptosis, autophagy, inflammation, and fibrosis) will facilitate further drug development and patient treatment. Presently, a substantial body of evidence suggests that the regulation of epigenetic processes contributes to cardiac repair following MI, with DNA methylation being among the notable epigenetic factors involved. This article will review the research on the mechanism of DNA methylation regulation after MI to provide some insights for future research and development of related drugs.
心肌梗死(MI)给社会带来了巨大的医学和经济负担,心肌梗死后的心脏修复涉及一系列复杂的过程。了解关键机制(如细胞凋亡、自噬、炎症和纤维化)将有助于进一步的药物开发和患者治疗。目前,大量证据表明,表观遗传过程的调节有助于心肌梗死后的心脏修复,DNA甲基化是其中值得注意的表观遗传因素之一。本文将综述心肌梗死后DNA甲基化调控机制的研究,为未来相关药物的研发提供一些见解。